Combined Resources Will Improve Cardiovascular-Kidney-Metabolic Care

For Release 8 a.m. CT/9 a.m. ET, Wednesday, Oct. 1, 2025

The missions of the CMCA and American Heart Association are closely aligned, focusing on comprehensive risk reduction and improving the quality of care and outcomes of patients with cardiometabolic disease. In addition, they both aim to accomplish these goals by supporting a patient-centered, team-based approach.

Founded by Saint Luke’s Mid America Heart Institute in Kansas City, Mo., under the medical direction of Mikhail Kosiborod, M.D., the CMCA began as a bold initiative to reshape cardiometabolic care. The CMCA was established through the Saint Luke’s Michael and Marlys Haverty Cardiometabolic Center of Excellence, which designed and successfully implemented a novel approach to treating Type 2 diabetes, pre-diabetes, and related cardiovascular conditions together - rather than addressing conditions or risk factors separately - providing team-based, comprehensive care specifically tailored to each patient.

The unique care model was recognized in top medical journals, and as health care systems across the country expressed interest in adopting the care model, the CMCA was launched. To date, CMCA members have observed statistically significant improvements in quality of care and clinical outcomes.

“Since launching the Cardiometabolic Center Alliance in 2020, we have witnessed an increasing demand to expand our collaborative team-based care model supporting not only patients, but the care teams and health systems dedicated to their care as well,” said Melissa Magwire, RN, MSN, CDCES, program director of the CMCA. “Our members have contributed substantially to advancing our mission of improving the lives of those living with cardiometabolic disease. By working with the American Heart Association, we now have the opportunity to expand and scale these efforts, enabling us to help even more people live longer, healthier lives.”

The Heart Association and the CMCA have an established collaborative relationship based on their shared mission. The strengths and expertise of CMCA will enhance the Heart Association’s development of a Cardiovascular-Kidney-Metabolic Center of Excellence certification program. The CMCA membership includes a suite of clinical protocols, clinical materials, program support for 22 cardiometabolic centers and a five-year longitudinal dataset of patient-level cardiometabolic data. The Heart Association will lead program development, implementation and clinical support for all existing CMCA members.

“The American Heart Association is proud to carry the torch forward toward integrated, patient-centered care for people with cardiovascular, kidney and metabolic conditions,” said Mariell Jessup, M.D., FAHA, Chief Science & Medical Officer of the American Heart Association. “This is a rare opportunity to optimize the synergy between the two organizations and combine efforts and resources for greater impact.”

CMCA leadership will transition to committee and staff roles at the American Heart Association.

Additional Resources:

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

About the Cardiometabolic Center Alliance

The Cardiometabolic Center Alliance is a national collaborative of healthcare organizations committed to the mission of improving the quality of care and outcomes in patients with cardiometabolic disease. Across its aligned member sites, care is delivered via a standardized, patient-centered, team-based, comprehensive risk-reduction approach based on a novel care model designed and successfully implemented by Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence in Kansas City, Missouri. 

Based on the initial data, under this model the rates of optimal guideline-directed medical therapy substantially increased over the national average, ensuring that patients with T2D receive care that is aimed at both optimizing diabetes management and providing comprehensive cardiovascular risk reduction with therapies proven to improve outcomes.

Media Inquiries for the American Heart Association:

American Heart Association: Maggie Francis: Maggie.Francis@heart.org; 214-706-1173

Saint Lukes: Lindsey Stich: lstich@saintlukeskc.org

Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.